Stay Informed with BrainChipTM Investor Resources
BrainChip’s CEO, Sean Hehir, provides a commercial update for BrainChip. In the presentation, Sean discusses BrainChip’s strategy, execution against the strategy and recent highlights from the business. At the conclusion of the presentation Sean also addresses a number of recent questions from shareholders.
BrainChip is the worldwide leader in edge AI on-chip processing and learning. The company’s first-to-market neuromorphic processor, Akida™, mimics the human brain to analyze only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Keeping machine learning local to the chip, independent of the cloud, also dramatically reduces latency while improving privacy and data security.
BrainChip enables effective edge compute to be universally deployable across real-world applications such as connected cars, consumer electronics, and industrial IoT.
BrainChip is proving that on-chip AI, close to the sensor, is the future for its customers’ products and the planet.
Learn how to receive your shareholder communications electronically for faster access to company updates, reports, and announcements—delivered directly to your inbox in a secure, paperless format.
This first IR Brief introduces our IR Briefs program—a new, ongoing initiative designed to improve transparency, consistency, and understanding of our business, our markets, and the technology landscape in which we operate. This program is educational in nature. It is intended to help shareholders better understand how we think about our strategy, technology, and industry trends, rather than to announce or signal new developments.
Brainchip’s Chief Development Officer Jonathon Tapson presents the 2026 Technology Roadmap presentation live from Sydney, Australia. Dr. Tapson shares the company’s upcoming product strategy, including development plans for Akida, Gen AI, tools, models and hardware offerings.
The BrainChip Technology Roadmap was presented on 6 May 2025. Watch the recording to hear Dr. Jonathan Tapson discuss Akida’s Edge AI performance, upcoming platform advancements, and emerging market opportunities.
The Brainchip 2024 AGM was held in Sydney on 21 May 2024. Watch a recording of the AGM here, including the CEO & CTO presentations, the Q&A with shareholders and the voting procedures for the business of the meeting.
Receiving your shareholder communications electronically is the best way to stay informed and will assist BrainChip with minimizing paper usage. If you haven’t already, we encourage you to make the switch to paperless communications and provide us with your email address.
To make the change, login to www.investorserve.com.au, add your email address via ‘My Details’ on the left-hand side of the screen and click ‘Communication Options’ to select the communication options you would like to set to email.
You can make a standing election as to how you would like to receive certain documents including annual reports, meeting-related documents (for example notices of meeting and proxy/voting forms) and payment statements.
You can also make a one-of request to receive a document in physical or electronic form by contacting the registry on enquiries@boardroomlimited.com.au.
You will also be able to access Shareholder Documents such as our Annual Report, Notice of Meeting and other documents relating to shareholder meetings when they are published on our website or made available on the ASX platform.
BrainChip Inc
23041 Avenida De La Carlota #250
Laguna Hills CA 92653
T 949.784.0040
F 949.784.0050
BrainChip Holdings Ltd
Level 12 225 George St Sydney NSW 2000 AU
T 61.2.8016.2841
BrainChip Research Institute
Level 2 / 182 St George’s Terrace, Perth, Western Australia 6000 Australia
T 61.8.8600.9662
BrainChip SAS
8 Rue Henri Jansou 31200 Toulouse France
T 33.5.6100.9145
Brainchip Systems India Pvt Ltd
H. No: 6-3-1090/B/4
5th Floor, North-East Corner, Rajbhavan Road, Hyderabad, Telangana, India 500082
T 91.98.494.78130
HLB Mann Judd (WA Partnership) Level 4, 130 Stirling
Street 6000 Australia
Phone:+618 9227 7500
Web: www.hlb.com.au
Boardroom Pty Limited
Level 12, 225 George St Sydney NSW 2000
GPO Box 3993 Sydney NSW2001
Phone: (02)92909600
Fax: (02)92790664
enquiries@boardroomlimited.com.au
boardroomlimited.com.au
Maddock’s Angel Place, Level 27, 123 Pitt Street, Sydney NSW 2000 Australia
Telephone:+612 9291 6197
Pillsbury Winthrop Shaw Pittman LP
Four Embarcadero Center, 22nd Floor, San Francisco, CA 94111
Phone:+1(415)983-1540
Depositary receipts (DRs) are negotiable U.S. securities issued by a U.S. bank, referred to as a “depositary bank,” that typically represent a non-U.S. company’s equity. DRs trade freely in global markets and facilitate cross-border trading.
DRs allow non-U.S. companies to make their shares available outside their home markets and allow investors in the U.S. and elsewhere to easily invest in companies on a more global basis.
Investors in the United States can benefit from holding ADRs rather than ordinary shares in the issuer’s home market, because ADRs trade, clear and settle according to United States market conventions.ADRs allow US investors to diversify into non-US securities and hold these in their US brokerage accounts. ADRs also allow easy comparison to securities of similar companies as well as access to price and trading information, U.S. dollar dividend payments and corporate action notifications.
BNY Mellon is the depositary bank and plays a key role in the process of issuance andcancellation of ADRs.
For more information, please visit:
www.adrbnymellon.com
www.adrbnymellon.com/resources/dr-basics
An ADR ratio provides the number of underlying shares represented by one ADS. 1 BrainChip ADR represents 40 ordinary BRN shares on the Australian Securities Exchange (ASX). The two securities trade very close to parity once the ADR ratio and foreign exchange aspects are accounted for.
An ADR isa negotiable certificate issued by a depositary bank to represent a specific number of shares of a foreign company traded on a U.S. exchange. An ADS (American Depositary Share) is the share issued under the ADR agreement which is actually traded.
Converting ordinary shares into ADRs can be done through an investment advisor or broker.To convert your ordinary shares into ADRs:
ADR issuers generally have full information in English about themselves on their websites. ADRs listed on U.S. exchanges provide holders with the same level of information as any other U.S. security with trading information readily available. Please visit BrainChip’s shareholder site to find further information including annual reports, quarterly updates, investor presentations and market announcements.
A registered holder is one whose name appears on the books of the depositary. The registered holder is considered the owner of the record. A beneficial holder is one whose holdings are registered in a name other than his or her own, such as the name of the broker, bank, or nominee.
For registered owners, ownership is registered by the depositary bank and is evidenced by an account statement provided by the depositary. Registered owners can hold physical ADR certificates.
Please contact BNY Mellon for more information.
For additional questions about ADRs please contact: BNY Mellon Shareowner Services
P. O. Box 505000
Louisville, KY 40233-5000
U.S. Toll Free Telephone: 1-888-BNY-ADRS (1-888-269-2377)
Telephone for International Callers: 1-201-680-6825
Website: www.mybnymdr.com
E-Mail: shrrelations@cpushareownerservices.com
Never miss an important update. Sign up to receive email alerts about BrainChip latest investor news, ASX announcements, financial reports, and company updates—delivered directly to your inbox.
In this tenth episode of BrainChip’s Investor Podcast Series, Trevor Franz, Managing Director of Lancaster Grove Capital, presents questions to BrainChip CEO Sean Hehir about specifics regarding the Company’s study on redomiciling, strategy and the latest updates on the development of customers and products.
In this ninth episode of BrainChip’s Investor Podcast Series, Dawe presents questions to Pia Turcinov, Non-Executive Director Chair of the Remuneration Nomination Committee, and Jelena Tasker, Client Partner, Executive Pay Governance at Korn Ferry, about specifics regarding the Company’s remuneration strategy and policies, and how important remuneration is in attracting and retaining skilled professionals.
Join CEO Sean Hehir and Director of Global Investor Relations Tony Dawe for BrainChip’s latest investor update. They’ll discuss the evolving AI landscape, recent customer agreements, and the company’s strategic direction for 2025. Key topics include the impact of the DeepSeek launch, new contracts, insights from CES 2025, and strategies for navigating foreign currency risks. Don’t miss this opportunity to gain valuable insights into BrainChip’s progress and priorities.
